Retroviral integration: Site matters
Here, we review genomic target site selection during retroviral integration as a multistep process in which specific biases are introduced at each level. The first asymmetries are introduced when the virus takes a specific route into the nucleus. Next, by co‐opting distinct host cofactors, the integ...
Saved in:
Published in | BioEssays Vol. 37; no. 11; pp. 1202 - 1214 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Cambridge
Blackwell Publishing Ltd
01.11.2015
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Here, we review genomic target site selection during retroviral integration as a multistep process in which specific biases are introduced at each level. The first asymmetries are introduced when the virus takes a specific route into the nucleus. Next, by co‐opting distinct host cofactors, the integration machinery is guided to particular chromatin contexts. As the viral integrase captures a local target nucleosome, specific contacts introduce fine‐grained biases in the integration site distribution. In vivo, the established population of proviruses is subject to both positive and negative selection, thereby continuously reshaping the integration site distribution. By affecting stochastic proviral expression as well as the mutagenic potential of the virus, integration site choice may be an inherent part of the evolutionary strategies used by different retroviruses to maximise reproductive success.
Retroviral integration is a multistep process moulded by nuclear entry, host cofactors and target recognition by the viral integrase. At each level, biases are introduced and the resulting distribution is reshaped by host selection processes. By affecting gene expression, site selection represents a selectable part of the retroviral evolutionary strategy. |
---|---|
Bibliography: | National Institute of Allergy and Infectious Diseases Research Foundation - Flanders (FWO) University of California at San Francisco (UCSF) Center For AIDS Research - No. P30 AI027763 KU Leuven Research Fund IAP BelVir (BelSpo) - No. FP7 CHAARM International AIDS Society istex:F82E89F8F7DCC1F802A60BCD0D323CFD6013F6FA ark:/67375/WNG-CRVH987M-9 Office of AIDS Research ArticleID:BIES201500051 Eranet EUREKA and the Creative and Novel Ideas in HIV Research Program (CNIHR) ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0265-9247 1521-1878 |
DOI: | 10.1002/bies.201500051 |